Richard Limehouse
Direktor/Vorstandsmitglied bei GeneVentiv Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Richard Limehouse
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
GeneVentiv Therapeutics, Inc.
 GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race.
2
| Holding Company | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Richard Limehouse
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Nabgen, Inc. | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 2 |
Sektoral
Operativ
| Director/Board Member | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
| President | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Chengwen Li | 2 |
| Damon R Race | 1 |
- Börse
- Insiders
- Richard Limehouse
- Unternehmensverbindungen
